menu
    • menu

    Company profile for AdvanCell

    NEW Drugs in Dev.: 3
    Evonik

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    End-to-end drug development, specializing in high-potency softgels and liquids, providing global partners with a competitive advantage.

    Virtual Booth

    Contact Supplier

    Kewpie is your partner for Sodium Hyaluronate & Hyaluronic Acid// CEP, USDMF, KDMF & JDMF registered.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    AdvanCell is a radiopharmaceutical company developing next-generation cancer treatments AdvanCell’s targeted alpha therapies are powered by a platform technology – a world-first alpha isotope generator which addresses the greatest unmet need in targeted alpha therapy – the reliable and scalable supply of isotope.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    AdvanCellAustralia Flag
    Country
    Country
    Australia
    Address
    Address
    Level 7, Macquarie House, 167 Macquarie Street, Sydney, NSW, 2000
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://advancell.com.au/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Advancell Receives Initial High-Activity Thorium-228 Delivery
    Advancell Receives Initial High-Activity Thorium-228 Delivery

    08 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251208309663/en/AdvanCell-Receives-First-Delivery-of-High-Activity-Thorium-228-Highlighting-a-Unique-Industry-Capability-and-Expertise-Essential-to-Scaling-Lead-212-Production-for-Targeted-Alpha-Therapies

    BUSINESSWIRE
    08 Dec 2025
    Share Share
    AdvanCell Starts Phase 2 ADVC001 Trial for Prostate Cancer
    AdvanCell Starts Phase 2 ADVC001 Trial for Prostate Cancer

    02 Dec 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251202480467/en/AdvanCell-Initiates-Phase-2-Expansion-Trial-of-ADVC001-a-Novel-Targeted-Alpha-Therapy-for-Prostate-Cancer

    BUSINESSWIRE
    02 Dec 2025
    Share Share
    AdvanCell Names Philina Lee, PhD as CEO to Drive Global Growth
    AdvanCell Names Philina Lee, PhD as CEO to Drive Global Growth

    17 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251117627738/en/AdvanCell-Appoints-Philina-Lee-PhD-as-Chief-Executive-Officer-to-Lead-US-Expansion-and-Drive-Global-Growth

    BUSINESSWIRE
    17 Nov 2025
    Share Share
    Advancell To Attend Jefferies Global Healthcare Conference
    Advancell To Attend Jefferies Global Healthcare Conference

    11 Nov 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20251111303258/en/AdvanCell-to-participate-in-Jefferies-Global-Healthcare-Conference-in-London

    BUSINESSWIRE
    11 Nov 2025
    Share Share
    Advancell's 212Pb-Advc001 Shows Safety And Anti-Tumor Activity
    Advancell's 212Pb-Advc001 Shows Safety And Anti-Tumor Activity

    18 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/18/3168943/0/en/AdvanCell-s-212Pb-ADVC001-demonstrates-encouraging-safety-and-compelling-anti-tumor-activity-in-Phase-1b-in-prostate-cancer.html

    GLOBENEWSWIRE
    18 Oct 2025
    Share Share
    Advancell Names Andrew Kay Chair Of Board
    Advancell Names Andrew Kay Chair Of Board

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167621/0/en/AdvanCell-appoints-experienced-biotech-and-pharma-leader-Andrew-Kay-as-Chair-of-the-Board-of-Directors.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search